Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tannic acid Potential treatment - pre-clinical evidence Natural product Antiviral Mar/30/2021 1 0
Omega-3 polyunsaturated fatty acids Potential treatment - clinical evidence Natural product Unknown Mar/29/2021 1 0
Indole-3-carbinol Potential treatment - pre-clinical evidence Natural product Antiviral Mar/24/2021 1 0
Tubocurarine Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Ginkgolide M Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Mezerein Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021 1 0
Hernandezine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 1 0
Neferine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 1 0
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Phycourobilin Potential treatment - theoretical effect Natural product Antiviral Mar/20/2021 1 0